Crossmark

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study

Crossref DOI link: https://doi.org/10.1007/s40801-020-00184-w

Published Online: 2020-02-28

Published Print: 2020-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Szerman, Nestor https://orcid.org/0000-0002-9821-7958
Basurte-Villamor, Ignacio https://orcid.org/0000-0001-9898-4105
Vega, Pablo https://orcid.org/0000-0002-6085-8602
Martinez-Raga, Jose https://orcid.org/0000-0002-2856-6562
Parro-Torres, Carlos

Cambra Almerge, Julia https://orcid.org/0000-0002-7381-2136
Grau-López, Lara https://orcid.org/0000-0003-1297-1819
De Matteis, Mario https://orcid.org/0000-0001-9654-9150
Arias, Francisco https://orcid.org/0000-0003-0740-9282
License Information

Text and Data Mining valid from 2020-02-28

Version of Record valid from 2020-02-28
More Information

Article History

First Online: 28 February 2020